Quantitative bioassay of human interleukin 1 and interleukin 2 activities
Shimizu, S.; Konda, S.
Rinsho Byori. Japanese Journal of Clinical Pathology 33(4): 365-370
1985
ISSN/ISBN: 0047-1860 PMID: 3876458 Document Number: 262768
Document emailed within 1 workday
Related Documents
Radeke, H.H.; Martin, M.; Topley, N.; Kaever, V.; Resch, K. 1991: Differential biological activities of human interleukin-1 alpha and interleukin-1 beta European Cytokine Network 2(1): 51-59Kierszenbaum, F.; Lopez, H.M.; Sztein, M.B. 1996: Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes Journal of Parasitology 82(4): 652-656
Réglier-Poupet, H.; Hakim, J.; Gougerot-Pocidalo, M.A.; Elbim, C. 1998: Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood European Cytokine Network 9(4): 633-638
Ward, L.D.; Shi, P.T.; Simpson, R.J. 1992: Binding of anti-human-interleukin-6 monoclonal antibodies to synthetic peptides of human interleukin-6 studied using surface plasmon resonance Biochemistry International 26(3): 559-565
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Wissing, K.M.; Desalle, F.; Abramowicz, D.; Willems, F.; Leo, O.; Goldman, M.; Alegre, M.L. 1999: Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice Transplantation 68(5): 677-684
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36
Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551
Yokota, T. 2005: Class i cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 187-192
Qiu, H.B.; Chen, D.C.; Pan, J.Q.; Liu, D.W.; Ma, S. 1999: Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 in mouse alveolar macrophages Zhongguo Yao Li Xue Bao 20(3): 271-275
Airoldi, I.; Guglielmino, R.; Carra, G.; Corcione, A.; Gerosa, F.; Taborelli, G.; Trinchieri, G.; Pistoia, V. 2002: The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes Haematologica 87(4): 434-442
Spiegelberg, H.L.; Falkoff, R.J.; O'Connor, R.D.; Beck, L. 1991: Interleukin-2 inhibits the interleukin-4-induced human IgE and IgG4 secretion in vivo Clinical and Experimental Immunology 84(3): 400-405
Shinkura, H.; Imazeki, I.; Yamazaki, M.; Oda, Y.; Kotoh, M.; Mihara, M. 1998: In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates Anticancer Research 18(2a): 1217-1221
Balashova, T.A.; Pashkov, V.S.; Onoprienko, L.V.; Mikhaleva, I.I.; Mareeva, T.I.; Petrova, E.E.; Nesmeianov, V.A.; Ivanov, V.T. 1991: Study of the interaction of the monoclonal antibody to human interleukin-2 and its Fab-fragment with synthetic peptides --interleukin-2 fragments by (1)H-NMR Bioorganicheskaia Khimiia 17(11): 1470-1486
Zhang, Q.-p.; Xie, L.-k.; Zhang, L.-j.; Tan, J.-q. 2005: Apoptosis in human germinal centre B cells by means of CC chemokine receptor 3 expression induced by interleukin-2 and interleukin-4 Chinese Medical Journal 118(8): 665-670
Warrington, R.J. 1988: Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. a role for overproduction of interleukin-2 in human autoimmunity? Journal of Rheumatology 15(4): 616-620
Henrotin, Y.E.; Labasse, A.H.; Simonis, P.E.; Zheng, S.X.; Deby, G.P.; Famaey, J.P.; Crielaard, J.M.; Reginster, J.Y. 1999: Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro Clinical and Experimental Rheumatology 17(2): 151-160
Kreitman, R.J.; Puri, R.K.; Pastan, I. 1995: Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma Cancer Research 55(15): 3357-3363
Fietta, A.; Meloni, F.; Francioli, C.; Morosini, M.; Bulgheroni, A.; Casali, L.; Gialdroni Grassi, G. 2001: Virulence of Mycobacterium tuberculosis affects interleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes International Journal of Tissue Reactions 23(4): 113-125
Banchereau, J. 1995: Converging and diverging properties of human interleukin-4 and interleukin-10 Behring Institute Mitteilungen 1995(96): 58-77